Loading
S2Medical AB (publ) Stock: price and insider trades · Sweden
SE·Mcap SEK 4.4M
S2Medical AB (publ): what insiders have been doing
Only a handful of insider records exist for S2Medical AB (publ), the last one from 1 October 2026, too few to describe a trend. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 22,065 of 24,148 companies
20.7
score / 100
Value7
Quality34
FCF yld-31%
Earn yld·
EV/EBITDA·
ROE-70%
Gross mgn98%
Net mgn-70%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.00
Analyst consensus
Income statement
RevenueSEK 14.4M
Gross profitSEK 14M98% margin
EBITDA-SEK 8.8M-61% margin
Net income-SEK 10.1M-67.6% margin
Valuation
P/Book0.3x
Beta2.27
Balance sheet & cash
Market capSEK 4.4M
Free Cash Flow-SEK 1.3M
Profitability & ownership
ROE-69.6%
ROA-5.6%
% insiders31.2%
% institutions10.1%
Last declaration on 1 October 2026
Declarations1 total
54,583,380 shares@ SEK 0.0033.68% mcap100.0% of flowAktieFI:csv-ba45f3e7717a4812085c
1 of 1 declaration
About S2Medical AB (publ)
S2Medical AB (publ) is a company listed on the XSTO market, specializing in the development of innovative solutions for wound treatment. It focuses on improving clinical outcomes through its advanced products.
